Eli Lilly to Manufacture GLP-1 Weight-Loss Pill in US

Eli Lilly to Manufacture GLP-1 Weight-Loss Pill in US

Eli Lilly will manufacture its orforglipron GLP-1 weight-loss pill in the US, avoiding tariffs and aligning with the 'Make America Healthy Again' initiative. Production aims for global availability by 2026. Orforglipron treats diabetes and promotes weight loss.